1. Home
  2. RBKB vs DTIL Comparison

RBKB vs DTIL Comparison

Compare RBKB & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rhinebeck Bancorp Inc.

RBKB

Rhinebeck Bancorp Inc.

N/A

Current Price

$13.11

Market Cap

200.9M

Sector

Finance

ML Signal

N/A

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

N/A

Current Price

$10.73

Market Cap

197.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RBKB
DTIL
Founded
1860
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
200.9M
197.9M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
RBKB
DTIL
Price
$13.11
$10.73
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $29.40
AVG Volume (30 Days)
70.0K
★ 213.9K
Earning Date
10-29-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 215.00
N/A
EPS
★ 0.44
N/A
Revenue
$2,984,000.00
★ $1,070,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$29.61
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$9.51
$3.53
52 Week High
$17.99
$9.62

Technical Indicators

Market Signals
Indicator
RBKB
DTIL
Relative Strength Index (RSI) 59.99 80.44
Support Level $12.59 $6.12
Resistance Level $13.15 N/A
Average True Range (ATR) 0.18 0.78
MACD 0.03 0.39
Stochastic Oscillator 82.98 84.04

Price Performance

Historical Comparison
RBKB
DTIL

About RBKB Rhinebeck Bancorp Inc.

Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank, which is a New York-chartered stock savings bank. It provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management. The Bank's primary business activity is accepting deposits from the general public and using those funds together with borrowings, to originate commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and indirect automobile loans, and to purchase one- to four-family residential real estate loans and investment securities.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Share on Social Networks: